Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$25k
4 rounds on record
Latest round
$25k
Venture round · Oct 2017 · 8 yr ago
Grants
$526k
3 grants · CORDIS
Backers
1
Twelve Below
The money's age
Long since its last round
107 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 1, 2022
Won a grant $318k · CORDIS
Jun 1, 2020
Won a grant $98k · CORDIS
Oct 4, 2017
Raised a round Venture round $25k · SEC Form D
2017
Founded
May 1, 2015
Won a grant $110k · CORDIS
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Grant | Jun 2022 | $318k | — | CORDIS |
| Grant | Jun 2020 | $98k | — | CORDIS |
| Venture round | Oct 2017 | $25k | — | SEC Form D |
| Grant | May 2015 | $110k | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | Nome LLC | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Kevin DoranExecutive Officer, DirectorSEC Form D
Gary DingesExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers

Launch compliant AI-native campaigns for pharma & life sciences.

OutreachGenius raised $1.7M CAD to create the revenue revival infrastructure for home services franchisors Learn More About Us Case Studies…

AI-Enabled Personalized Therapeutics for Canine Cancer. Personalized therapeutics can offer a more hopeful prognosis. FidoCure®, developed…

We've been acquired, learn more here Venue Home Noble Experience Industries Case Studies Get the Noble Kit Venue Home Noble Experience…

Product Launch Introducing the Bretton AI Platform Read The New Standard Platform Customers Company Resources Blog Insights, tips, and…

Innovation and effectiveness for the treatment of rare and ultra-rare diseases.
Overview
Our Story Why Nome How It Works Programs Services Active Programs For Providers Learn Case Studies Articles Press Solving Rare FAQ Get started — About The operating system for personalized therapeutics. — Why We Exist The pharma model wasn't built for rare patients.
News
Nome utility board demands budget after 5 years without one
The Nome Joint Utility System is five years overdue for financial audits. Its board can't make informed budget decisions because management has also failed to produce a budget for five fiscal years.
Read more
Report
When one vector isn't enough: why dual-vector gene therapy matters
The first FDA-approved dual-AAV gene therapy solves a delivery problem that has limited the field for years. Here is why that matters for rare disease families.
Read more
Report
FDA's new prior knowledge guidance: why rare disease gene therapy no longer has to start from zero
For many rare disease families, every new therapy feels like building from scratch. FDA's draft guidance on prior knowledge points to a more connected path, where what we learn in one genome editing program can help carry the next one forward.
Read more
Report
KIZ-Mutation Retinitis Pigmentosa: A Textbook Case for Gene Replacement Therapy
Retinitis pigmentosa gene therapy is not one-size-fits-all. Here is how to tell which genes are built for gene replacement, using KIZ, one cause of inherited retinitis pigmentosa, as a worked example.
Read more
Report
Pro access
Upgrade to see all 24 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People

Kevin Doran
Executive Officer, Director

Gary Dinges
Executive Officer, Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Hillsboro
United States
HQ

Twelve Below